Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795247 · ClinicalTrials.gov registry record · NA
Comparison of 3 Techniques for Recreation of Anterior Cruciate Ligament Anatomic Footprint
A NA study, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02795247: Completed NA study, sponsored by OrthoCarolina Research Institute.
NCT02795247 is a NA study that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02795247, a NA study, has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the tomographic results of patients who underwent single-bundle anterior cruciate ligament reconstruction at the investigator's institution using the transtibial, accessory medial portal technique and the modified transtibial technique to determine which technique best recreates the anterior cruciate ligament anatomic footprint.
Primary Outcome
Used to measure tunnel position.
Interventions
- PROCEDURE Anterior Cruciate Ligament Reconstruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08-26 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT02795247 record still lists
NCT02795247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Anterior Cruciate Ligament Reconstruction is the first listed.
NCT02795247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02795247 about?
NCT02795247 is a clinical study titled "Comparison of 3 Techniques for Recreation of Anterior Cruciate Ligament Anatomic Footprint". The purpose of this study is to compare the tomographic results of patients who underwent single-bundle anterior cruciate ligament reconstruction at the investigator's institution using the transtibial, accessory medial portal technique and the modified transtibial technique to determine which techn...
What is the current status of trial NCT02795247?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-08-26. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT02795247?
The interventions under investigation include: Anterior Cruciate Ligament Reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT02795247?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02795247's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI